Paradoxically, these same patients showed hypomethylation of the IL-10 gene, suggesting concurrent activation of anti-inflammatory pathways (TGF-β, IL-10, IL-13) as part of the CARS that follows systemic inflammatory response syndrome (SIRS). The gene discussed is IL10; the disease is systemic inflammatory response syndrome.